DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1AVIR PHARMA INC.
03 1Accord healthcare
04 2Apotex Inc
05 1Arrotex Pharmaceuticals
06 1Aurobindo Pharma Limited
07 2Baxter Healthcare Corporation
08 1Flagship Biotech International Pvt. Ltd
09 1Fresenius Kabi Austria
10 1Fresenius Kabi USA
11 1Hainan Poly Pharm
12 1Hainan Shuangcheng Pharmaceuticals
13 2Hospira, Inc.
14 1JUNO PHARMACEUTICALS CORP.
15 1Jodas Expoim Pvt. Ltd
16 1Laboratorio Reig Jofre SA
17 1Maia Pharmaceuticals
18 1Meitheal Pharmaceuticals
19 1Pliva Hrvatska
20 2Sandoz B2B
21 1Slate Run Pharmaceuticals
22 1Stanex Drugs and Chemicals
23 1THE MEDICINES COMPANY UK LTD
24 2The Medic Ines Company UK Ltd
25 1The Medicines Company UK Ltd,
26 2Viatris
01 1Bivalirudin 250Mg 10 Units Parenteral Use
02 1INJECTABLE;INJECTION
03 13INJECTABLE;INTRAVENOUS
04 3Injection
05 1Lyo.Inj
06 2POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
07 3POWDER FOR SOLUTION
08 2Powder to concentrate to the Injection/infusion fluid, resolution
09 1SOLUTION
10 3SOLUTION;INTRAVENOUS
11 2Blank
01 5DISCN
02 2Generic
03 4Prescription
04 10RX
05 11Blank
01 2ANGIOMAX
02 1ANGIOMAX RTU
03 4Angiox
04 13BIVALIRUDIN
05 1BIVALIRUDIN ARX
06 2BIVALIRUDIN FOR INJECTION
07 2BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
08 1BIVALIRUDIN INJECTION
09 1Bivalirudin APOTEX
10 1Bivalirudin Reig Jofre
11 4Blank
01 2Australia
02 4Canada
03 1China
04 3India
05 1Italy
06 2Norway
07 2Sweden
08 17USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-05-26
Application Number : 201577
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-11-22
Application Number : 206551
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2017-07-06
Application Number : 204876
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-07-27
Application Number : 205962
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 250MG/50ML (5MG/ML)
Packaging :
Approval Date : 2017-12-21
Application Number : 208374
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 500MG/100ML (5MG/ML)
Packaging :
Approval Date : 2017-12-21
Application Number : 208374
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : BIVALIRUDIN FOR INJECTION
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 250MG/VIAL
Packaging : 5ML
Approval Date :
Application Number : 2435268
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2016-10-28
Application Number : 90189
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2019-10-23
Application Number : 210031
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2015-07-14
Application Number : 90811
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2015-07-14
Application Number : 90816
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Lyo.Inj
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : ANGIOMAX RTU
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 250MG/50ML (5MG/ML)
Packaging :
Approval Date : 2019-07-25
Application Number : 211215
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-07-16
Application Number : 91602
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date :
Application Number : 91206
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ANGIOMAX
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2000-12-15
Application Number : 20873
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ANGIOMAX
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 250MG/VIAL
Packaging : 10X5ML
Approval Date :
Application Number : 2246533
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2021-05-28
Application Number : 213078
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 250MG/ML
Packaging : 10 ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date :
Application Number : 91468
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : BIVALIRUDIN
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date : 2018-06-01
Application Number : 202471
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Angiox
Dosage Form : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
Dosage Strength : 250 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Sweden
Brand Name : Bivalirudin Reig Jofre
Dosage Form : POWDER FOR CONCENTRATE FOR SOLUTION FOR INJECTION
Dosage Strength : 250 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Angiox
Dosage Form : Bivalirudin 250Mg 10 Units Parenteral Use
Dosage Strength : 10 VIALS EV 250 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Angiox
Dosage Form : Powder to concentrate to the Injection/infusion fluid, resolution
Dosage Strength : 250 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Norway
Brand Name : Angiox
Dosage Form : Powder to concentrate to the Injection/infusion fluid, resolution
Dosage Strength : 250 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : BIVALIRUDIN INJECTION
Dosage Form : SOLUTION
Dosage Strength : 5MG/ML
Packaging :
Approval Date :
Application Number : 2505517
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : BIVALIRUDIN FOR INJECTION
Dosage Form : POWDER FOR SOLUTION
Dosage Strength : 250MG/VIAL
Packaging :
Approval Date :
Application Number : 2511452
Regulatory Info : Prescription
Registration Country : Canada
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
